The GLP-1 medications currently approved and used in clinical practice, primarily for the treatment of type 2 diabetes and obesity, include: Semaglutide: Ozempic, Wegovy, Rybelsus Tirzepatide: Mounjaro, Zepbound Liraglutide: Victoza, Saxenda Dulaglutide: Trulicity Exenatide: Byetta, Bydureon Expanding Beyond Obesity The therapeutic potential of GLP-1s extends beyond weight management
Clinical and meta-analytic data indicate that, although FBM reduction predominates, modest decreases in LBM can occur, particularly during substantial weight loss [17, 18]
If you are taking oral semaglutide (Rybelsus), it is advised to take it 30 minutes before your first food, beverage, or other oral medications of the day with a small amount of water
Our findings provide valuable insights into the structural basis of functional versatility of tirzepatide and peptide 20